Varicella vaccine for immunocompromised children: Results of collaborative studies in the United States and Canada

Journal of Infectious Diseases

Volumn 174, Issue SUPPL. 3, 1996, Pages

  LaRussa, Philip ^a   Steinberg, Sharon ^a   Gershon, Anne A ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

CANADA; CHICKENPOX; CHILD; DRUG SAFETY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOGENICITY; LEUKEMIA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RASH; REVIEW; STEROID THERAPY; UNITED STATES; VACCINATION;

EID: 0029973943     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.supplement_3.s320     Document Type: Review

References (28)

1. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T, Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974;2:1288-90.
2. Feldman S, Hughes W, Daniel C. Varicella in children with cancer: 77 cases. Pediatrics 1975;80:388-97.
3. Gershon A. Immunoprophylaxis of varicella-zoster infection. Am J Med 1984; 76:672-7.
4. Gershon AA, Steinberg S, Gelb L. Live attenuated varicella vaccine: use in immunocompromised children and adults. Pediatrics 1986;78(suppl): 757-62.
5. Gershon AA, Steinberg SP. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 1989;320:892-7.
6. Gershon AA, LaRussa P, Steinberg S. Live attenuated varicella vaccine: current status and future uses. Semin Pediatr Infect Dis 1991;2:171-8.
7. Hardy IB, Gershon A, Steinberg S, LaRussa P, et al. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. N Engl J Med 1991;325:1545-50.
8. Lawrence R, Gershon A, Holzman R, Steinberg S, NIAID Varicella Vaccine Collaborative Study Group. The risk of zoster after varicella vaccination in children with leukemia. N Engl J Med 1988;318:543-8.
9. Lydick E, Kuter BJ, Zajac BA, Guess HA. Association of steroid therapy with vaccine-associated rashes in children with acute lymphocytic leukaemia who received Oka/Merck varicella vaccine. NIAID Varicella Study Group. Vaccine 1989;7:549-53.
10. Tsolia M, Gershon A, Steinberg S, Gelb L. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. J Pediatr 1990; 116:184-9.
11. Bogger-Goren S, Bernstein JM, Gershon A, Ogra PL. Mucosal cell mediated immunity to varicella zoster virus: role in protection against disease. J Pediatr 1984; 105:195-9.
12. Martin JH, Dohner D, Wellinghoff WJ, Gelb LD. Restriction endonuclease analysis of varicella-zoster vaccine virus and wild type DNAs. J Med Virol 1982;9:69-76.
13. Brunell P, Geiser C, Novelli V, Lipton S, Narkewicz S. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia. Pediatrics 1987;79:922-7.
14. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg S, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 1992;66:1016-20.
15. Kinchington PR, Remenick J, Ostrove J, Straus S, Ruyechan W, Hay J. Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42 base pair repeat sequence has homology to herpes simplex virus glycoprotein C. J Virol 1986; 59:660-8.
16. Hayakawa Y, Yamamoto T, Yamanishi K, Takahashi M. Analysis of varicella zoster virus (VZV) DNAs of clinical isolates by endonuclease HpaI. J Gen Virol 1986;67:1817-29.
17. Hughes P, LaRussa PS, Pearce JM, Lepow ML, Steinberg SP, Gershon A. Transmission of varicella-zoster virus from a vaccinee with underlying leukemia, demonstrated by polymerase chain reaction. J Pediatr 1994; 124:932-5.
18. Ross AH, Lencher E, Reitman G. Modification of chickenpox in family contacts by administration of gamma globulin. N Engl J Med 1962; 267:369-76.
19. Gershon A, LaRussa P, Steinberg S. Clinical trials in immunocompromised individuals. Pediatr Clin North Am 1996 (in press).
20. Gershon AA, LaRussa P, Steinberg S, Mervish N, Lo SH, Meier P. The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J Infect Dis 1996; 173:450-3.
21. Sato Y, Miyano T, Kawauchi K, Yokoyama M. Use of live varicella vaccine in acute leukemia and malignant lymphoma. Biken J 1984;27:111-3.
22. Ha K, Baba K, Ikeda T, Nishida M, Yabuuchi H, Takahashi M. Application of a live varicella vaccine in children with acute leukemia or other malignancies without suspension of anticancer therapy. Pediatrics 1980; 65:346-50.
23. Konno T, Yamaguchi Y, Minegishi M, Goto Y, Tsuchiyama S. A clinical trial of live attenuated varicella vaccine (Biken) in children with malignant diseases. Biken J 1984;27:73-5.
24. Nunoue T. Clinical observations on varicella-zoster virus vaccinees treated with immunosuppressants for a malignancy. Biken J 1984;27:115-8.
25. Arbeter A, Granowetter L, Starr S, Lange B, Wimmer R, Plotkin S. Immunization of children with acute lymphoblastic leukemia with live attenuated varicella vaccine without complete suspension of chemotherapy. Pediatrics 1990; 85:338-44.
26. Takahashi M, Asano Y, Kamiya H, Baba K, Yamanishi K. Active immunization for varicella zoster virus. In: Nahmais AJ, Dowdle WR, Schnazi RE, eds. The human herpesviruses. New York: Elsevier, 1981:414-31.
27. Takahashi M. Clinical overview of varicella vaccine: development and early studies. Pediatrics 1986; 78 S:736-41.
28. Broyer M, Boudailliez B. Varicella vaccine in children with chronic renal insufficiency. Postgrad Med J 1985;61(suppl 4):103-6.